All diseases on Foresight

Similar documents
BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.

CHRONIC MYELOGENOUS LEUKEMIA

Foresight Carrier Screen

Foresight Carrier Screen

Foresight Carrier Screen

Foresight Carrier Screen

CARRIER SCREEN - LIST OF DISORDERS

Foresight Carrier Screen

CLINICAL AND HUMAN TESTING

Foresight Carrier Screen

Foresight Carrier Screen

The Counsyl Foresight Carrier Screen

23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function

CarrierMap. Genetic Counseling. Technology TABLE OF. Sample Report CONTENTS. New Offerings. Recombine Facts. Disease List

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:

Sperm Donor Profile. Asian American Indian African American/Black. Caucasian/White East Indian Latino/Hispanic

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem

Family Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis

JOHN DOE JANE DOE. Reproductive Risk Summary. Counsyl Test Results Summary

SAMPLE. Carrier Screening Results Report v2.2 Page 1/8

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks

Evolve FamilyReady Carrier Screen

רשימת המחלות הנסקרות בבדיקה

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia

PREDICAGEN LLC REPORT

PATIENT EDUCATION. carrier screening INFORMATION

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the

Further expansion of the neonatal screening panel in the Netherlands

Newborn Screening: Focus on Treatment

For Your Baby s Health Department of Health

Diagnose a broad range of metabolic disorders with a single test, Global MAPS

High Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s)

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy

Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995

Survey of prenatal testing for genetic disorders in Japan: Recent report

Utility of Microarrays in Molecular Genetics

FRAMBU. Resource Centre for Rare Disorders

Residual risks by ethnicity

Results Recipient Ordering Healthcare Professional Male Details Female Details

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert

Summary of Results CARRIER STATUS DNA INSIGHT. Result: Carrier, Heterozygote. Protected Health Information. Propionic Acidemia

Expanded carrier screening for monogenic disorders: where are we now?

HEMATOPOIETIC CELL TRANSPLANTATION FOR GENETIC DISEASES AND ACQUIRED ANEMIAS

Standard Therapies - Cord Blood

Positive Newborn Screens: What do you do next?

Approach to diagnosis of metabolic diseases

Clinical Approach to Diagnosis of Lysosomal Storage Diseases

Our partners worldwide. CENTOGENE Report: Diagnosed cases of rare diseases at CENTOGENE. January 2012 to June 2016.

Beyond the case for NBS in South Africa. Chris Vorster 28/05/2016

What s New in Newborn Screening?

NEWBORN METABOLIC SCREEN, MINNESOTA

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School

Title: Assessing Recommendations Related To Timeliness of Newborn Screening

QUESTION. Personal Behavior History. Donor Genetic History. Donor Medical History. Family Medical History PERSONAL BEHAVIOR HISTORY. Never N/A.

Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet

Strand Neuromuscular Disorders Test: Genes & Test Selection

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School

HERES Carrier Screening TEST

ORIGINAL RESEARCH ARTICLE

INBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides

Newborn Screening: Blood Spot Disorders

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)

Knowledge is power. Plan ahead with GeneAware.

EURORDIS Member Organisations - Diseases - ERN Groupings Working Document

Newborn Screening in Manitoba. Information for Health Care Providers

CARRIER SCREENING PANEL

Results for Trendy. Explanation of Results

Coagulation factor VII deficiency. Hemophilia A (German Shepherd Dog, type 1) Pyruvate kinase deficiency (Labrador Retriever type)

A Guide for Prenatal Educators

N.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

The Compelling Benefits of Routine 2 nd NBS: A Fifteen-Year Review in Washington State. Saving lives with a simple blood spot

Expanded Carrier Screening: What s Best?

FABRY DISEASE 12/30/2012. Ataxia-Telangiectasia. Ophthalmologic Signs of Genetic Neurological Disease

BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW.

COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS

panel tests assessing multiple genes at the same time for the diagnosis of one or more related disorders

Newborn Screening in Washington State Saving lives with a simple blood spot

disease carrier status PANEL DETAILS VERSION Risk Details JANE MILLER JOHN MILLER NEGATIVE CARRIER * NEGATIVE MILD CONDITION NEGATIVE

Corporate Medical Policy

Considerations in Choosing Screening Conditions: One (US) Approach

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)

Results for Dar. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results

Inborn Errors of Metabolism (IEM)

Newborn bloodspot testing

HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics

Should Universal Carrier Screening be Universal?

PGD: A Celebration of 20 years:

HEREDITARY METABOLIC DISEASES

Transcription:

All diseases on Foresight Disease 11-Beta-Hydroxylase- Deficient Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 3-Hydroxy-3-Methylglutaryl- CoA Lyase Deficiency 3-Methylglutaconic Aciduria Type III (a.k.a. Costeff Optic Atrophy Syndrome) 6-Pyruvoyl-Tetrahydropterin Synthase Deficiency Adenosine Deaminase Deficiency Adrenoleukodystrophy 1 Alpha Thalassemia Alpha-Mannosidosis Alpha-Sarcoglycanopathies (Including Limb-Girdle Muscular Dystrophy Type 2D)

Alport Syndrome, X-Linked 1 Alstrom Syndrome Andermann Syndrome Argininemia Argininosuccinic Aciduria Aspartylglycosaminuria Ataxia With Isolated Vitamin E Deficiency Ataxia-Telangiectasia Autoimmune Polyendocrinopathy Syndrome Type I Autosomal Recessive Congenital Ichthyosis 1 Autosomal Recessive Osteopetrosis 1 Bardet-Biedl Syndrome 1 Bardet-Biedl Syndrome 10 Bardet-Biedl Syndrome 12

Bardet-Biedl Syndrome 2 Beta-Sarcoglycanopathies (Including Limb-Girdle Muscular Dystrophy Type 2E) Biotinidase Deficiency Bloom Syndrome Calpainopathies (Including Limb-Girdle Muscular Dystrophy Type 2A) Canavan Disease Carbamoylphosphate Synthetase I Deficiency Carnitine Palmitoyltransferase Deficiency Type IA Carnitine Palmitoyltransferase Deficiency Type II Cartilage-Hair Hypoplasia Cerebrotendinous Xanthomatosis Citrullinemia Cohen Syndrome

COL4A3-related Alport syndrome COL4A4-related Alport syndrome Combined Pituitary Hormone Deficiency 2 Congenital Adrenal Hypoplasia with Hypogonadotropic Hypogonadism 1 Congenital Disorder of Glycosylation Type Ia Congenital Disorder of Glycosylation Type Ib Congenital Disorder of Glycosylation Type Ic Cystic Fibrosis Cystinosis D-Bifunctional Protein Deficiency Delta-Sarcoglycanopathies (Including Limb-Girdle Muscular Dystrophy Type 2F)

DFNB1A (a.k.a. GJB2-Related Nonsyndromic Hearing Loss and Deafness) Dihydrolipoamide Dehydrogenase Deficiency Dysferlinopathies (Including Limb-Girdle Muscular Dystrophy Type 2B) Dyskeratosis Congenita Dystrophinopathies (Including Duchenne Muscular Dystrophy and Becker Muscular Dystrophy) 1 ERCC6-Related Disorders (Including Cockayne Syndrome Type B) ERCC8-Related Disorders (Including Cockayne Syndrome Type A) EVC-related Ellis-van Creveld Syndrome and Weyers Acrofacial Dysostosis EVC2-related Ellis-van Creveld Syndrome and Weyers Acrofacial Dysostosis

Fabry Disease 1 Familial Dysautonomia Familial Hyperinsulinemic Hypoglycemia Type 1 Familial Hyperinsulinemic Hypoglycemia Type 2 Familial Mediterranean Fever Fanconi Anemia Complementation Group A Fanconi Anemia Complementation Group C Fragile X Syndrome 1 Galactokinase Deficiency with Cataracts Galactosemia Gamma-Sarcoglycanopathies (Including Limb-Girdle Muscular Dystrophy Type 2C) Gaucher Disease Glutaricaciduria Type I

Glycine Encephalopathy Glycine Encephalopathy Glycogen Storage Disease Ia Glycogen Storage Disease Ib/Ic Glycogen Storage Disease II (a.k.a. Pompe Disease) Glycogen Storage Disease III GM1-Gangliosidoses (Including Mucopolysaccharidosis Type IVB, Morquio Syndrome B) GRACILE Syndrome HADHA-Related disorders (Including Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency and Trifunctional Protein Deficiency) Hb Beta Chain-Related Hemoglobinopathy Hereditary Fructose Intolerance

Has a well-defined Hexosaminidase A Deficiency (Including Tay-Sachs Disease) HGSNAT-Related diseases (Including Mucopolysaccharidosis Type IIIC, a.k.a. Sanfilippo C) Holocarboxylase Synthetase Deficiency Homocystinuria due to Cystathionine Beta-Synthase Deficiency Hurler Syndrome Hydrolethalus Syndrome Hypophosphatasia Inclusion Body Myopathy~2 Isovaleric Acidemia Junctional Epidermolysis Bullosa, LAMA3-Related Junctional Epidermolysis Bullosa, LAMB3-Related Junctional Epidermolysis Bullosa, LAMC2-Related

Krabbe Disease Leigh Syndrome, French- Canadian Type Lipoid Adrenal Hyperplasia Lysosomal Acid Lipase Deficiency (Including Cholesteryl Ester Storage Disease and Wolman Disease) Maple Syrup Urine Disease Type 1B Maple Syrup Urine Disease Type IA Maple Syrup Urine Disease Type II Medium Chain Acyl-CoA Dehydrogenase Deficiency Megalencephalic Leukoencephalopathy With Subcortical Cysts Menkes Syndrome; Occiptal Horn Syndrome; Distal Spinal Muscular Atrophy X-Linked 1 Merosin-Deficient Congenital Muscular Dystrophy

diagnosis is Metachromatic Leukodystrophy Methylmalonic Acidemia and Homocystinuria, cblc Type Methylmalonic Acidemia, cbla Type Methylmalonic Acidemia, cblb Type Methylmalonic Acidemia, Mut Type MKS1-Related diseases (Including Meckel Syndrome 1 and Bardet- Biedl Syndrome 13) Mucolipidosis II/III Mucolipidosis III Gamma Mucolipidosis IV Mucopolysaccharidosis II (a.k.a. Hunter Syndrome) 1 Mucopolysaccharidosis Type IIIB (Sanfilippo B) Muscular Dystrophy- Dystroglycanopathy 5 (Including Limb-Girdle Muscular Dystrophy Type 2I)

diagnosis is Muscular Dystrophy- Dystroglycanopathy Type 3 (Including Muscle-Eye-Brain Disease) Muscular Dystrophy- Dystroglycanopathy Type 4 (Including Walker-Warburg Syndrome and Fukuyama Congenital Muscular Dystrophy) MYO7A-Related Disorders (Including Usher Syndrome Type 1B, DFNB2, and DFNA11) Nemaline Myopathy 2 Nephrotic Syndrome Type 2 Nephrotic Syndrome Type~1 Neuronal Ceroid Lipofuscinosis 1 Neuronal Ceroid Lipofuscinosis 2 Neuronal Ceroid Lipofuscinosis 3 Neuronal Ceroid Lipofuscinosis 5 Neuronal Ceroid Lipofuscinosis 6 Neuronal Ceroid Lipofuscinosis 8 (Including Northern Epilepsy)

diagnosis is Niemann-Pick Disease Type A/B Niemann-Pick Disease Type C1/D Niemann-Pick Disease Type C2 Nijmegen Breakage Syndrome Ornithine Transcarbamylase Deficiency 1 Pendred Syndrome Peroxisome Biogenesis Disorder 1 Peroxisome Biogenesis Disorder 3 Peroxisome Biogenesis Disorder 4 Peroxisome Biogenesis Disorder 5 Peroxisome Biogenesis Disorder 6 Peroxisome Biogenesis Disorder 9 (a.k.a. Rhizomelic Chondrodysplasia Punctata Type 1) Phenylalanine Hydroxylase Deficiency Polycystic Kidney Disease Type I

diagnosis is Primary Carnitine Deficiency Primary Hyperoxaluria Type I Primary Hyperoxaluria Type II Primary Hyperoxaluria Type III Propionic Acidemia Complementation Group pcca Propionic Acidemia Complementation Group pccbc Pycnodysostosis Pyruvate Carboxylase Deficiency Salla Disease Sandhoff Disease Sanfilippo, Type A Segawa Syndrome Short Chain Acyl-CoA Dehydrogenase Deficiency Sjogren-Larsson Syndrome Smith-Lemli-Opitz Syndrome

diagnosis is Spastic Ataxia, Charlevoix-Saguenay Type Spastic Paraplegia 15 Menkes Syndrome; Occiptal Horn Syndrome; Distal Spinal Muscular Atrophy X-Linked 1 Spondylothoracic Dysostosis 2 Sulfate Transporter-Related Osteochondrodysplasia TMEM216-Related Disorders (Including Joubert Syndrome 2) Tyrosinemia Type II Tyrosinemia Type II USH1C-Related Disorders (Including Usher Syndrome Type IC and DFNB18A) USH2A-Related Disorders (Including Usher Syndrome Type 2A and Retinitis Pigmentosa 39) Usher Syndrome Type 1F Usher Syndrome Type 3A

diagnosis is Very Long Chain Acyl-CoA Dehydrogenase Deficiency Wilson Disease X-Linked Combined Immunodeficiency (Including SCID)* X-Linked Juvenile Retinoschisis 1 X-Linked Myotubular Myopathy 1 Xeroderma Pigmentosum Group A Xeroderma Pigmentosum Group C 1 Inherited in an X-linked manner.